Dr Eng Chon Boon sadly passed away on 18 December 2024. An article honouring him was published in Biopreservation and Biobanking: doi.org/10.1089/bio.2025.0041.

Dr Eng was director of the Tissue Repository at National University Hospital (NUH), ran the Hospital-based Cancer Registry at the National University Cancer Institute (NCIS), and held an adjunct position at the Saw Swee Hock School of Public Health, NUS. He was principal person-in-charge of tissue banks across the NUHS cluster and lead PI for the Singapore Integrated Network of Biorepositories (SINB), Singapore’s convenor for ISO/TC276 Biotechnology, and on the editorial board of Biopreservation and Biobanking.

He was a past recipient of the ISBER special service award (2010) and held numerous voluntary roles within ISBER over the years. He had many publications, book chapters and a patent in biobanking, and consulted for international biobanks over 15 years. Further info: Publications.

Dr Rajeev Singh, MD, MBA, is Director, Biorepository at Houston Methodist Research Institute, Houston, TX, USA. A trained pathologist with basic medical and specialist degrees from India and an MBA from the USA, he has been a biobanker for 15 years across biobanks in Singapore and the US.

An active ISBER member for 15 years, he has been involved with the Biospecimen Science, Standards and Finance committees, co-chaired sessions and led round-table discussions, and reviewed the 4th edition of ISBER Best Practices. His focus areas are biospecimen quality and donor perspectives; he is driving his biorepository towards CAP accreditation and is a certified CAP Biorepository Inspector.

Mr Barjinder Sahota is a barrister practising at the independent Bar and a member of the Honourable Society of the Inner Temple, London (7 Bell Yard, London, WC2A 2JR). He has a special interest in biobanking and has served as a lay member on two committees involving biobank access and research.

Jeanne-Hélène di Donato has worked on biobank professionalisation for almost 25 years — first as manager of the French AFM-Généthon biobank for 14 years, then for 15 years as a consultant through her company 3C-R. She was a member of the French delegation to the OECD BRC Task Force and led the working group on best-practice guidelines for human-derived material, and co-authored French Standard NF S 96-900 for biobank quality-management systems.

She is certified for consulting and training, an auditor (NF S 96-900, ISO 20387, ISO 9001), manager of the largest francophone biobank network (Club 3C-R, 125 biobanks), and a lecturer on the biobank-managers Master’s at the Catholic University of Lyon. She is a member of the French Ethical Committee for clinical trials and of Eurobiobank, ISBER and ESBB.

Riad (MSc, MEng) trained at the National Institute of Health and Medical Research (Inserm) Paris, in the Neuropharmacokinetics unit, focusing on drug transport across the blood-brain barrier. He worked as an R&D research engineer at Synt:em (brain-targeted peptide vectorisation) and Auris Medical (therapeutic peptides for tinnitus).

In 2010 he joined Amiens-Picardie University Hospital (CHU-AP), where he is Head of the Tumorothèque de Picardie. He has 15 years’ experience in biobanking, quality management and biological-sample valorisation across clinical and industrial research, sits on the Strategic Orientation Council of CHU-AP, and teaches in clinical pharmacology and oncology therapeutic-development programmes at UPJV.

Dr Betsou (PhD, HDR) is Chief Scientific Officer at IBBL, with 25 years’ experience in molecular diagnostics, disease-oriented biobanking and biospecimen research, and 15 years applying ISO 9001 and ISO 17025 to biobanks. She holds three patents, has authored more than 100 peer-reviewed publications, and teaches on several biobanking courses. She chairs the ISBER Biospecimen Science Working Group and the Proficiency Testing Advisory Group, and is Luxembourg’s national delegate to ISO REMCO and ISO TC276.

Liam Burke Masterson is a Clinical Partnership Manager at Genuity Science, building collaborations with clinicians and academic cohort custodians. Genuity is a contract genomics, data-sourcing and analytics organisation headquartered in Boston, with offices in Dublin and Reykjavík.

He holds an MSc in Project and Programme Management and has an extensive biobanking background, having been a key member of the Qatar Biobank team from its early stages through collaboration with Imperial College London. He spent over seven years in the Middle East before returning to Ireland in 2018.

CEO and co-founder of Genobank.io, a serial entrepreneur with 15+ years in UNIX, cybersecurity and cloud computing and 5+ years in blockchain and smart contracts, recently specialising in the intersection of privacy laws, genomics and bioinformatics. He holds a BS in Electronics Engineering and an MBA from IPADE Business School, with executive programmes at Stanford GSB and Singularity University.

Neil is a Fellow and Lifetime Member of the Institute of Chartered Accountants (ICAEW) and has worked as a professional CFO across publicly listed and larger privately owned businesses. Since 2014 he has advised businesses and not-for-profits on strategic planning, performance improvement, turnarounds, corporate governance, M&A, IPOs, capital raisings and investor relations.